Market Cap : 76.85 M | Enterprise Value : 79.44 M | P/E (TTM) : | P/B : 1.66 |
---|
APEN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APEN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
vs
industry |
vs
history |
||
---|---|---|---|
Cash-to-Debt | 0.92 |
66% of the 330 Companies in the Global Medical Devices industry. ( Industry Median: 2.32 vs. APEN: 0.92 ) Ranked among companies with meaningful Cash-to-Debt only. |
APEN'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.16 Med: No Debt Max: No Debt Current: 0.92 |
Equity-to-Asset | 0.47 |
75% of the 309 Companies in the Global Medical Devices industry. ( Industry Median: 0.63 vs. APEN: 0.47 ) Ranked among companies with meaningful Equity-to-Asset only. |
APEN'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.27 Med: 0.5 Max: 1 Current: 0.47 |
Debt-to-Equity | 0.67 |
76% of the 220 Companies in the Global Medical Devices industry. ( Industry Median: 0.30 vs. APEN: 0.67 ) Ranked among companies with meaningful Debt-to-Equity only. |
APEN'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.52 Med: 0.01 Max: 1.18 Current: 0.67 |
Piotroski F-Score: 3 |
|
Altman Z-Score: -2.05 |
|
Beneish M-Score: -3.12 |
|
WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
vs
industry |
vs
history |
||
---|---|---|---|
Operating Margin % | -47.12 |
71% of the 312 Companies in the Global Medical Devices industry. ( Industry Median: 1.96 vs. APEN: -47.12 ) Ranked among companies with meaningful Operating Margin % only. |
APEN'
s Operating Margin % Range Over the Past 10 Years
Min: -410.17 Med: -48.41 Max: 15.13 Current: -47.12 |
Net Margin % | -56.22 |
72% of the 312 Companies in the Global Medical Devices industry. ( Industry Median: 1.40 vs. APEN: -56.22 ) Ranked among companies with meaningful Net Margin % only. |
APEN'
s Net Margin % Range Over the Past 10 Years
Min: -400.56 Med: -50.59 Max: 33.45 Current: -56.22 |
ROE % | -69.32 |
81% of the 304 Companies in the Global Medical Devices industry. ( Industry Median: 0.95 vs. APEN: -69.32 ) Ranked among companies with meaningful ROE % only. |
APEN'
s ROE % Range Over the Past 10 Years
Min: -231.4 Med: -93.77 Max: 146.27 Current: -69.32 |
ROA % | -32.55 |
71% of the 332 Companies in the Global Medical Devices industry. ( Industry Median: -0.26 vs. APEN: -32.55 ) Ranked among companies with meaningful ROA % only. |
APEN'
s ROA % Range Over the Past 10 Years
Min: -126.81 Med: -29.84 Max: 46.07 Current: -32.55 |
ROC (Joel Greenblatt) % | -294.20 |
76% of the 327 Companies in the Global Medical Devices industry. ( Industry Median: 3.87 vs. APEN: -294.20 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
APEN'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -8243.06 Med: -252.55 Max: 687.79 Current: -294.2 |
3-Year Revenue Growth Rate | -41.50 |
93% of the 254 Companies in the Global Medical Devices industry. ( Industry Median: 4.30 vs. APEN: -41.50 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
APEN'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -41.5 Med: 9.95 Max: 145.1 Current: -41.5 |
3-Year EBITDA Growth Rate | 77.50 |
97% of the 232 Companies in the Global Medical Devices industry. ( Industry Median: 7.50 vs. APEN: 77.50 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
APEN'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0 Med: 6.65 Max: 77.5 Current: 77.5 |
3-Year EPS without NRI Growth Rate | 70.30 |
95% of the 223 Companies in the Global Medical Devices industry. ( Industry Median: 7.80 vs. APEN: 70.30 ) Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only. |
APEN'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0 Med: -18.3 Max: 70.3 Current: 70.3 |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
Guru | Date | Action |
Impact | Price Range (Average)* |
Change from Average | Comment | Current Shares |
---|
Industry: | Medical Devices » Medical Devices NAICS: 339112 SIC: 3842 | |
---|---|---|
Compare: | TSE:5187, OTCPK:ZYXI, NAS:MSON, NAS:EYES, OTCPK:BTCY, XKRX:056090, XKRX:208370, ROCO:4745, NAS:VIVE, XKRX:156100, LSE:IDH, LSE:BQE, XKRX:004080, OSTO:BACTI B, XPAR:MKEA, TSXV:VMD, XKRX:216280, OTCPK:IVOB, AMEX:XTNT, XKRX:059210 » details | |
Traded in other countries: | HQ8F.Germany, | |
Headquarter Location: | USA |
vs
industry |
vs
history |
||
---|---|---|---|
PB Ratio | 1.66 |
64% of the 310 Companies in the Global Medical Devices industry. ( Industry Median: 3.06 vs. APEN: 1.66 ) Ranked among companies with meaningful PB Ratio only. |
APEN'
s PB Ratio Range Over the Past 10 Years
Min: 0.35 Med: 4.68 Max: 116.89 Current: 1.66 |
PS Ratio | 1.04 |
76% of the 294 Companies in the Global Medical Devices industry. ( Industry Median: 3.15 vs. APEN: 1.04 ) Ranked among companies with meaningful PS Ratio only. |
APEN'
s PS Ratio Range Over the Past 10 Years
Min: 0.04 Med: 6.06 Max: 409.8 Current: 1.04 |
EV-to-Revenue | 1.29 |
74% of the 309 Companies in the Global Medical Devices industry. ( Industry Median: 3.73 vs. APEN: 1.29 ) Ranked among companies with meaningful EV-to-Revenue only. |
APEN'
s EV-to-Revenue Range Over the Past 10 Years
Min: -2.5 Med: 5 Max: 426.8 Current: 1.29 |
Current Ratio | 2.42 |
59% of the 324 Companies in the Global Medical Devices industry. ( Industry Median: 2.71 vs. APEN: 2.42 ) Ranked among companies with meaningful Current Ratio only. |
APEN'
s Current Ratio Range Over the Past 10 Years
Min: 0.43 Med: 2.9 Max: 9.25 Current: 2.42 |
Quick Ratio | 1.81 |
57% of the 324 Companies in the Global Medical Devices industry. ( Industry Median: 2.03 vs. APEN: 1.81 ) Ranked among companies with meaningful Quick Ratio only. |
APEN'
s Quick Ratio Range Over the Past 10 Years
Min: 0.43 Med: 2.65 Max: 9.25 Current: 1.81 |
Days Inventory | 195.87 |
65% of the 294 Companies in the Global Medical Devices industry. ( Industry Median: 143.61 vs. APEN: 195.87 ) Ranked among companies with meaningful Days Inventory only. |
APEN'
s Days Inventory Range Over the Past 10 Years
Min: 113.83 Med: 180.34 Max: 196.82 Current: 195.87 |
Days Sales Outstanding | 60.64 |
53% of the 276 Companies in the Global Medical Devices industry. ( Industry Median: 69.21 vs. APEN: 60.64 ) Ranked among companies with meaningful Days Sales Outstanding only. |
APEN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 10.45 Med: 57.93 Max: 716.86 Current: 60.64 |
Days Payable | 184.74 |
92% of the 261 Companies in the Global Medical Devices industry. ( Industry Median: 58.34 vs. APEN: 184.74 ) Ranked among companies with meaningful Days Payable only. |
APEN'
s Days Payable Range Over the Past 10 Years
Min: 83.36 Med: 197.28 Max: 272.17 Current: 184.74 |
vs
industry |
vs
history |
||
---|---|---|---|
3-Year Average Share Buyback Ratio | -310.50 |
98% of the 244 Companies in the Global Medical Devices industry. ( Industry Median: -5.70 vs. APEN: -310.50 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
APEN'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -310.5 Med: -31 Max: -3.2 Current: -310.5 |
vs
industry |
vs
history |
||
---|---|---|---|
Price-to-Net-Current-Asset-Value | 351.00 |
99.99% of the 207 Companies in the Global Medical Devices industry. ( Industry Median: 7.79 vs. APEN: 351.00 ) Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only. |
APEN'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.56 Med: 10.14 Max: 717 Current: 351 |
Price-to-Tangible-Book | 9.49 |
87% of the 276 Companies in the Global Medical Devices industry. ( Industry Median: 4.50 vs. APEN: 9.49 ) Ranked among companies with meaningful Price-to-Tangible-Book only. |
APEN'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.54 Med: 9.82 Max: 368.82 Current: 9.49 |
Price-to-Median-PS-Value | 0.17 |
96% of the 237 Companies in the Global Medical Devices industry. ( Industry Median: 1.02 vs. APEN: 0.17 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
APEN'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01 Med: 1.12 Max: 59.01 Current: 0.17 |
Earnings Yield (Greenblatt) % | -36.65 |
83% of the 332 Companies in the Global Medical Devices industry. ( Industry Median: 0.74 vs. APEN: -36.65 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
APEN'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -8845.9 Med: -15.7 Max: 3014.6 Current: -36.65 |
Revenue (TTM) (Mil) $ | 61.81 |
---|---|
EPS (TTM) $ | -1.84 |
Beta | 0.95 |
Volatility | 57.18% |
52-Week Range $ | 3.02 - 9.65 |
Shares Outstanding (Mil) | 17.29 |
Dec18 | Dec19 | Dec20 | Dec21 | |
---|---|---|---|---|
Revenue (Mil $) | 60 | 56 | 58 | 66 |
EBIT (Mil $) | ||||
EBITDA (Mil $) | ||||
EPS ($) | -1.87 | -1.50 | -1.05 | -0.70 |
EPS without NRI ($) | -1.87 | -1.50 | -1.05 | -0.70 |
EPS Growth Rate (Future 3Y To 5Y Estimate) | N/A | |||
Dividends per Share ($) |
|
Weekly CFO Buys Highlight Jun 27 2018 |
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurg Mar 30 2018 |
Weekly CFO Buys Highlight Jul 30 2017 |
GF Chat